Novel HIV vaccine approach shows promise in “landmark” trial
The vaccine was able to target the desired immune cells and could become the first stage of a multi-step vaccine strategy to combat HIV.
Click to view the original at europeanpharmaceuticalreview.com
Hasnain says:
This is amazing.
“According to the organisations, the vaccine successfully stimulated the production of the rare immune cells needed to generate antibodies against HIV in 97 percent of participants.”
Posted on 2021-04-04T18:47:28+0000